PFN1 E117G is also under debate of rather being a benign polymorphism or a potential ALS risk factor, as it is also present in control patients (Fratta et al., 2014; Smith et al., 2015). This evidence concerns the gene PFN1 and amyotrophic lateral sclerosis.